Literature DB >> 17493502

Insect sting anaphylaxis.

David B K Golden1.   

Abstract

Anaphylaxis to insect stings has occurred in 3% of adults and can be fatal even on the first reaction. Large local reactions are more frequent but rarely dangerous. The chance of a systemic reaction to a sting is low (5% to 10%) in large local reactors and in children with mild (cutaneous) systemic reactions, and varies between 25% and 70% in adults depending on the severity of previous sting reactions. Venom skin tests are most accurate for diagnosis, but the radioallergosorbent test (RAST) is an important complementary test. The degree of sensitivity on skin test or RAST does not predict the severity of a sting reaction reliably. Venom sensitization can be detected in 25% of adults, so the history is most important. Venom immunotherapy is 75% to 98% effective in preventing sting anaphylaxis. Most patients can discontinue treatment after 5 years, with very low residual risk of a severe sting reaction.

Entities:  

Mesh:

Year:  2007        PMID: 17493502      PMCID: PMC1961691          DOI: 10.1016/j.iac.2007.03.008

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  67 in total

1.  Side-effects of insect venom immunotherapy: results from an EAACI multicenter study. European Academy of Allergology and Clinical Immunology.

Authors:  H Mosbech; U Müller
Journal:  Allergy       Date:  2000-11       Impact factor: 13.146

2.  Clinical correlation of the venom-specific IgG antibody level during maintenance venom immunotherapy.

Authors:  D B Golden; I D Lawrence; R H Hamilton; A Kagey-Sobotka; M D Valentine; L M Lichtenstein
Journal:  J Allergy Clin Immunol       Date:  1992-09       Impact factor: 10.793

3.  Unusual reactions following insect stings. Clinical features and immunologic analysis.

Authors:  W C Light; R E Reisman; M Shimizu; C E Arbesman
Journal:  J Allergy Clin Immunol       Date:  1977-05       Impact factor: 10.793

Review 4.  Stinging insect hypersensitivity: a practice parameter update.

Authors:  John E Moffitt; David B K Golden; Robert E Reisman; Rufus Lee; Richard Nicklas; Theodore Freeman; Richard deshazo; James Tracy; I Leonard Bernstein; Joann Blessing-Moore; David A Khan; David M Lang; Jay M Portnoy; Diane E Schuller; Sheldon L Spector; Steven A Tilles
Journal:  J Allergy Clin Immunol       Date:  2004-10       Impact factor: 10.793

5.  Development and validation of a health-related quality-of-life questionnaire in patients with yellow jacket allergy.

Authors:  Joanne N G Oude Elberink; Jan G R de Monchy; David B k Golden; Jan-Leendert P Brouwer; Gordon H Guyatt; Anthony E J Dubois
Journal:  J Allergy Clin Immunol       Date:  2002-01       Impact factor: 10.793

6.  Insect sting allergy and venom immunotherapy: a model and a mystery.

Authors:  David B K Golden
Journal:  J Allergy Clin Immunol       Date:  2005-03       Impact factor: 10.793

7.  Lack of reproducibility of a single negative sting challenge response in the assessment of anaphylactic risk in patients with suspected yellow jacket hypersensitivity.

Authors:  H H Franken; A E Dubois; H J Minkema; S van der Heide; J G de Monchy
Journal:  J Allergy Clin Immunol       Date:  1994-02       Impact factor: 10.793

8.  Treatment failures with whole-body extract therapy of insect sting allergy.

Authors:  D B Golden; J Langois; M D Valentine; A Kagey-Sobotka; L M Lichtenstein
Journal:  JAMA       Date:  1981-11-27       Impact factor: 56.272

9.  Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venom.

Authors:  Joanne N G Oude Elberink; Jan G R De Monchy; Sicco Van Der Heide; Gordon H Guyatt; Anthony E J Dubois
Journal:  J Allergy Clin Immunol       Date:  2002-07       Impact factor: 10.793

10.  Insect-sting challenge in 324 subjects with a previous anaphylactic reaction: current criteria for insect-venom hypersensitivity do not predict the occurrence and the severity of anaphylaxis.

Authors:  P W van der Linden; C E Hack; A Struyvenberg; J K van der Zwan
Journal:  J Allergy Clin Immunol       Date:  1994-08       Impact factor: 10.793

View more
  24 in total

Review 1.  Danger-Associated Molecular Patterns (DAMPs): the Derivatives and Triggers of Inflammation.

Authors:  Seema Patel
Journal:  Curr Allergy Asthma Rep       Date:  2018-09-28       Impact factor: 4.806

2.  Dual function of a bee venom serine protease: prophenoloxidase-activating factor in arthropods and fibrin(ogen)olytic enzyme in mammals.

Authors:  Young Moo Choo; Kwang Sik Lee; Hyung Joo Yoon; Bo Yeon Kim; Mi Ri Sohn; Jong Yul Roh; Yeon Ho Je; Nam Jung Kim; Iksoo Kim; Soo Dong Woo; Hung Dae Sohn; Byung Rae Jin
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

3.  The neurotoxicological effects of mastoparan Polybia-MPII at the murine neuromuscular junction: an ultrastructural and immunocytochemical study.

Authors:  Thalita Rocha; Bibiana M de Souza; Mario S Palma; Maria Alice da Cruz-Höfling; John Buchanan Harris
Journal:  Histochem Cell Biol       Date:  2009-06-05       Impact factor: 4.304

4.  Wasp sting induced STEMI with complete coronary artery occlusion: a case of Kounis syndrome.

Authors:  Benjamin Cross; Tawfiqur Rahman Choudhury; Mark Hindle; Gavin Galasko
Journal:  BMJ Case Rep       Date:  2017-09-07

5.  The use of concentrated heat after insect bites/stings as an alternative to reduce swelling, pain, and pruritus: an open cohort-study at German beaches and bathing-lakes.

Authors:  Christian Müller; Beatrice Großjohann; Lutz Fischer
Journal:  Clin Cosmet Investig Dermatol       Date:  2011-12-15

Review 6.  Anaphylaxis to insect venom allergens: role of molecular diagnostics.

Authors:  Markus Ollert; Simon Blank
Journal:  Curr Allergy Asthma Rep       Date:  2015-05       Impact factor: 4.806

7.  Analysis of serum peptidome patterns of patients stung by honey bees.

Authors:  Weiguo Sui; Fengyan Li; Yuwen Hou; Yong Dai
Journal:  J Res Med Sci       Date:  2013-06       Impact factor: 1.852

8.  Management of insect sting hypersensitivity: an update.

Authors:  Robert D Pesek; Richard F Lockey
Journal:  Allergy Asthma Immunol Res       Date:  2013-02-25       Impact factor: 5.764

9.  Transient Unexplained Shock in 30-year-old Trauma Patient.

Authors:  Farzad Rahmani; Hanieh Ebrahimi Bakhtavar; Kavous Shahsavari Nia; Neda Mohammadi
Journal:  Emerg (Tehran)       Date:  2014

10.  The correlation between anti phospholipase A2 specific IgE and clinical symptoms after a bee sting in beekeepers.

Authors:  Jan Matysiak; Joanna Matysiak; Anna Bręborowicz; Paweł Dereziński; Zenon J Kokot
Journal:  Postepy Dermatol Alergol       Date:  2016-06-17       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.